Sponsored Webcast: The Exciting Journey of Machine Translation Deployment in the Life Science Industry

RAC Credits
Live Webcasts Live Webcasts Virtual Programs Virtual Programs
Wednesday, 06 May 2020 (11:00 AM) - Wednesday, 06 May 2020 (12:00 PM) Eastern Time (US & Canada)

The life sciences industry is experiencing a demand for growing multilingual content, compelling the industry to apply machine translation and artificial Intelligence (AI).Due to increasing market pressure, members of the clinical, regulatory, and pharmaco-vigilance communities are exploring how to inform their customers, patients, and stakeholders around the world, faster and more cost-effectively.

For instance, neural machine translation (NMT) is a machine translation approach that applies a vast artificial neural network toward predicting the likelihood of a sequence of words, often in the form of whole sentences. NMT is outcompeting traditional types of translation systems and is quickly moving to the forefront of machine translation. However, NMT and AI are still evolving technologies that require constant fine-tuning to reach acceptable clinical accuracy and regulatory adequacy. 

Join us for a webcast to learn how best practices can leverage NMT and AI in a highly regulated industry. Upon completion of the webcast, you will be able to: 

  • Understand the use case of AI and NMT in highly regulated industries.
  • Assess the risk of failure against the benefits of deploying NMT and AI on your clinical and regulatory content.
  • Learn how to leverage best practices for the responsible application of NMT and AI on your current content profile.

Learning Level:

Basic: Content is introductory in nature and requires no requisite knowledge or experience to grasp concepts and related exercises. Basic educational activities are meant to establish a foundation of knowledge and/or competence that will be expanded upon in practice or in higher-level activities.

Who Should Attend?

  • Regulatory affairs professionals
  • Clinical trial professionals
  • Pharmacovigilance professionals


    Jill Balcerzak, vice president of global solutions, RWS Life Sciences

    Jill Balcerzak is an articulate and collaborative localization executive with 16 years of deep subject matter expertise in the Life Science sector. In her tenure in the language services industry, she has been a leader in a wide variety of roles and partner with the world's most demanding and innovative customers. Balcerzak is a forward thinker with a customer focus, value-driven mentality working to bridge multiple disciplines to build meaningful solutions for the world’s leading pharmaceutical, medical device and biotech companies.

    Walter Smith, senior global solutions director, RWS Life Sciences

    For over 25 years, Walter Smith has been helping companies tackle the challenges of internationalizing and localizing their products and services for global markets, as well as guiding these companies through the intricacies of optimizing the customer experience on a global scale. He draws on his experience in business process analysis and optimization, product marketing and management, and content localization management to assess clients’ current-state processes, staffing, and technologies. Smith also recommends paths forward to address tactical and strategic objectives for clients’ international markets.

    Dave Ledley, solutions architect, RWS Life Sciences

    Dave Ledley has recently joined RWS Life Sciences from a large global pharmaceutical client who are leading the way in the adoption of machine translation. His knowledge of regulatory procedure within the pharmaceutical industry, and his extensive experience in providing innovative solutions within the regulatory space gives him a unique understanding of client expectations when implementing new technologies – from risk-versus-benefit analysis to implementation into an existing process framework.

    Discover more of what matters to you

    No taxonomy

    News »